Alkahest
Presence
Grifols is one of the...
Grifols is a company listed under the stock ticker GRFS (ES).
Grifols has a direct presence in 7 countries.Grifols has 10 subsidiaries including Alkahest, Biotest and Biotest Austria.
They are in:
- Pharmaceuticals82%
- Biotechnology9%
- Other9%
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Alkahest
- Karoly Nikolich, Chief Executive Officer and Chairman of the Board
- David Bell, Director
- Tony Wyss-Coray, Director
Popular executive movements at Grifols
- Nacho Abia will join the company as Chief Executive Officer on Apr. 1, 2024 (posted on February 6 2024).
- Raimon Grifols Roura, Chief Corporate Affairs Officer and Vice Chairman, is retiring (posted on December 25 2023).
- Albert Grifols Coma-Cros has joined the company as Director (posted on December 25 2023).
Click here to view some more movements at Grifols
Create your alert
to follow the executive moves at Alkahest.
Biotechnology
Grifols has 2,272 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
- Nuvation Bio has announced the acquisition of AnHeart (posted on April 12 2024).
Popular contacts in Biotechnology
News
Press releases by Alkahest
Social media about Alkahest
- Alkahest on Wikipedia, Google News & Yahoo Finance
- Alkahest on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Karoly Nikolich 
